Isomorphic Labs
AI
Markets
Isomorphic Labs Raises $2B to Prove AI Can Compress Drug Discovery Timelines
Google DeepMind's spinout secures what could be the largest AI-drug discovery financing ever, but delayed clinical trials test whether algorithms can match biology's pace.
AI
Isomorphic Labs Enters Human Trials With AI-Designed Drugs, Testing Industry’s $3 Billion Bet
DeepMind spinoff's 2026 clinical trials mark first major test of whether machine learning can genuinely reduce drug failure rates beyond early-stage screening.